

















































The	 objective	 of	 this	 study	 was	 to	 identify	 and	 delineate	 relevant	 patient	 outcomes	











Using	 the	 predetermined	 inclusion/exclusion	 criteria,	 nine	 reviewers	 working	 in	 pairs	
assessed	the	eligibility	of	the	identified	studies	based	on	titles	and	abstracts.	Papers	meeting	
the	 inclusion	criteria	were	retrieved	and	full	 texts	were	further	assessed.	Critical	Appraisal	
Skills	 Programme	 tools	 were	 used	 to	 assess	 the	 quality	 of	 the	 included	 studies.	 Data	 on	
nursing	sensitive	outcomes	were	extracted	independently	by	two	reviewers.	The	Outcome	








utility,	 health	 care	 resources,	 death).	 These	 fitted	 into	 10	 health	 intervention	 domains	 in	
keeping	 with	 the	 pre-specified	 conceptual	 framework	 for	 health:	 disease	 status,	
effectiveness,	safety,	function,	knowledge,	satisfaction,	psychological	status,	quality	of	 life,	
cost,	 death.	 A	 total	 of	 59	 measurement	 instruments	 were	 identified	 comprising	 patient	
reported	outcome	measures	(n=31),	and	biologic	measures	and	reports	(n=	28).	
Conclusions	
This	 review	 is	 notable	 in	 that	 it	 is	 the	 first	 to	 have	 identified,	 and	 reported,	 a	 set	 of	
















Rheumatology	 nursing	 is	 a	 practice	 specialty	which	 contributes	 significantly	 to	 the	
management	 of	 patients	 with	 rheumatoid	 arthritis	 (American	 Nurses	 Association	 and	
Rheumatology	 Nurses	 Society,	 2013,	 Carr	 A,	 2001,	 van	 Eijk-Hustings	 et	 al.,	 2012).	
Rheumatology	 nurses	 have	 many	 roles	 within	 the	 context	 of	 the	 multidisciplinary	 team	





education	 and	 experience	 of	 rheumatology	 nurses	 (Garner	 et	 al.,	 2017,	 Ryan,	 2017).	
Rheumatology	 nursing	 development	 follows	 a	 worldwide	 tendency	 among	 healthcare	
practitioners	 to	 provide	 a	 more	 proactive,	 evidence-based	 and	 patient-preference-based	
care	 (Laurant	M	et	 al.,	 2004,	 Loveman	et	 al.,	 2003,	Quill	 and	Holloway,	 2012).	 In	 2012,	 a	
European	 League	 against	 Rheumatism	 (EULAR)	 task	 force	 developed	 evidence-based	
recommendations	 for	 the	 role	 of	 the	 nurse	 in	 the	management	 of	 chronic	 inflammatory	
arthritis	 (van	 Eijk-Hustings	 et	 al.,	 2012).	 The	 recommendations	 were	 aimed	 to	 enhance	
standardisation	and	harmonisation	of	rheumatology	nursing	across	countries.		
While	 the	 evidence	 confirming	 that	 patient	 benefit	 from	 rheumatology	 nursing	
continues	 to	 grow,	 more	 high	 quality	 studies	 including	 international	 comparisons	 are	
required	to	further	strengthen	this	evidence	(van	Eijk-Hustings	et	al.,	2012).	However,	one	
of	 the	 critical	 challenges	 to	 evidence	 synthesis	 is	 lack	 of	 agreement	 on	 which	 outcome	
domains	 should	 be	 covered	 when	 evaluating	 rheumatology	 nursing	 care.	 Furthermore,	
methods	to	measure	outcomes	directly	related	to	nursing	interventions	are	limited	(Begley	
et	al.,	2010,	Gerrish,	2011).	This	hampers	comparability	of	studies	and	pooling	of	outcomes	
in	meta-analyses,	 and	 consequently	 limits	 clear	 and	 robust	 conclusions	 regarding	 nursing	
interventions	(Craig	et	al.,	2008,	Ndosi	et	al.,	2011).		
In	order	to	capture	the	valuable	and	unique	contribution	of	nursing	to	health	care,	it	
is	 important	 to	 identify	 outcomes	 that	 are	 sensitive	 to	 nursing	 (International	 Council	 of	
Nurses,	2009).	As	a	concept,	a	nursing	sensitive	outcome	can	be	defined	as	an	individual’s,	
family	or	community	state,	behaviour	or	perception	that	is	measured	along	a	continuum	in	
response	to	nursing	 intervention(s)	 (Moorhead	et	al.,	2013).	 In	 the	context	of	 this	study	a	
nursing	 sensitive	 outcome	 was	 defined	 as	 an	 individual’s	 area	 of	 health,	 behaviour	 or	
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set	 is	 intended.	 	 This	 framework	 comprises	 two	 overarching	 concepts	 (Impact	 of	 health	
Conditions	and	Pathophysiological	Manifestations).	Impact	of	health	conditions	encompass	





OMERACT	 recommends	 the	 identification	 of	 at	 least	 one	 valid,	 reliable	 and	 responsive	













and	 seven	 nurses	 and	 academics	 from	 Ireland,	 The	 Netherlands,	 the	 UK	 and	 the	 USA.	
Patient	 research	 partners	 are	 persons	 with	 a	 relevant	 disease	 who	 operate	 as	 active	
research	 team	 members	 on	 an	 equal	 basis	 with	 professional	 researchers,	 adding	 to	 the	
benefit	 of	 their	 experiential	 knowledge	 to	 a	 research	 project	 (de	 Wit	 et	 al.,	 2011).	 The	
patient	 research	 partners	 were	 all	 trained	 for	 and	 experienced	 in	 participating	 within	 all	
steps	of	the	OMERACT	research	process,	and	were	involved	in	the	study	from	its	inception.	
They	 participated	 as	 full	 researchers	 in	 the	 discussion	 about	 the	 necessity	 of	 this	 work;	
design	of	 the	 review;	study	selection	and	 in	 finalising	 the	manuscript.	A	 research	 librarian	
was	consulted	for	advice	on	search	terms	at	the	beginning	of	the	project	although	she	was	
not	part	of	the	research	team.	









Inclusion	 criteria	 were	 (i)	 patients	 with	 rheumatoid	 arthritis,	 in	 accordance	 with	
American	College	of	Rheumatology	classification	criteria	for	rheumatoid	arthritis	(Arnett	et	
al.,	1988)	and	the	American	College	of	Rheumatology/European	League	against	Rheumatism	
(ACR/EULAR)	 rheumatoid	 arthritis	 classification	 criteria	 (Aletaha	 et	 al.,	 2010),	 (ii)	 adult	
population	 age	 ≥	 16	 years	 (onset	 of	 arthritis	 prior	 to	 the	 age	 of	 16	 years	 is	 classified	 as	
juvenile	 idiopathic	arthritis	 (JIA),	as	distinct	 from	rheumatoid	arthritis	 (Petty	et	al.,	2004)),	
(iii)	rheumatology	nurse	as	part	of	the	care	team	or	intervention	delivery,	(iv)	dated	1990	–	
2016,	 (v)	 primary	 research	 only,	 (vi)	 English	 language,	 and	 (vii)	 quantitative	 studies	 with	
nursing	sensitive	outcomes.		
2.2.		Information	Sources	
A	 systematic	 literature	 search	 was	 executed	 in	 Medline,	 CINAHL,	 Ovid	 Nursing,	




preliminary	 searches	 were	 conducted	 to	 identify	 terms	 to	 encompass	 interventions	 and	
outcomes	 specific	 to	 rheumatology	 nursing.	 However,	 a	 large	 variation	 between	





The	 study	 selection	process	 comprised	7	 steps,	which	are	 summarised	 in	 Figure	2.	
Using	 EndNote®	 software	 results	 from	all	 database	 searches	were	merged	 and	duplicates	
were	 removed	 (steps	 1	 &	 2).	 For	 step	 3	 the	 review	 team	 sub-divided	 into	 four	 working	
groups,	minimum	two	 reviewers	per	group.	All	 abstracts	and	 titles	 that	 resulted	 from	 the	
search	were	 screened	 for	 eligibility	 using	 three	of	 the	 above	 inclusion	 criteria	 (adults	 age	
>16	 years	 at	 disease	 onset,	 nurse	 as	 part	 of	 care	 team	 or	 intervention	 delivery,	 primary	
research).	 Records	were	 retained	 if	 they	did	 not	 contain	 an	 abstract	 or	 if	 reviewers	were	
unable	 to	 ascertain	 if	 the	 above	 inclusion	 criteria	 applied.	 For	 step	 4	 the	 partners	 were	
rotated	between	working	groups	to	enhance	the	validity	in	re-screening	titles	and	abstracts.	
Only	 studies	 meeting	 the	 following	 criteria	 were	 retained:	 (i)	 quantitative	 studies	 with	
nursing	sensitive	outcomes	in	the	results	and	(ii)	English	language.	In	step	5,	full	texts	were	
obtained.	Papers	were	assessed	to	ensure	that	nursing	was	a	part	of	 the	 intervention	and	
reported	nursing	 sensitive	outcomes.	 In	 step	6,	 studies	with	mixed	diagnostic	 groups	 (i.e.	
rheumatoid	arthritis	and	psoriatic	arthritis)	and	 interventions	delivered	by	non-specialised	
rheumatology	nurses	 (for	example,	 generic	 smoking	cessations	programmes	not	delivered	
by	a	rheumatology	nurse),	were	excluded.	Step	7	was	an	update	of	the	literature	search.	
2.5.		Quality	Assessment		
Critical	 Appraisal	 Skills	 Programme	 tools	 (Cohort	 Checklist	 and	 Randomised	






results	 and	 questions	 9-11	 relate	 to	 relevance	 to	 practice	 (external	 validity)	 of	 the	 study.	




For	 this	 study,	 a	 data	 extraction	 tool	 was	 devised	 to	 guide	 the	 extraction	 of	
information	 from	 the	 records	 in	 line	 with	 the	 study	 aim.	 The	 data	 extracted	 included:	
author,	title,	origin,	year,	type	of	patients,	age	of	patients,	study	design,	language,	if	nursing	






Data	 synthesis	 was	 carried	 out	 qualitatively	 by	 one	 reviewer	 and	 subjected	 to	
rigorous	 discussion,	 cross	 checking	 and	 consensus	 by	 the	 research	 team.	 All	 nursing	
sensitive	 outcomes	 that	 were	 reported	 in	 the	 studies	 were	 delineated.	 Using	 a	 content	
analysis	approach,	context	specific	domains	for	this	study	were	identified	and	defined.	The	




Figure	 2	 presents	 the	 flow	 diagram	 of	 the	 systematic	 search.	 Of	 the	 820	 titles	
originally	 identified,	 115	 full	 texts	 were	 screened	 and	 eventually	 11	 papers	 reporting	 10	
studies	 (two	 papers	 (Hill	 et	 al.,	 1994	 and	 Hill,	 1997)	 reported	 results	 of	 one	 study)	were	
included	in	this	review.		
3.1.		Characteristics	of	the	included	studies	




Ryan	 et	 al.,	 2006,	 Tijhuis	 et	 al.,	 2003)	 and	 3	 observational	 studies	 comprised	 of	 2	 cohort	
studies	 (Maravic	 et	 al.,	 2000,	Watts	 et	 al.,	 2015)	 and	 1	 cross-sectional	 study	 (Arthur	 and	
Clifford,	 2004).	 The	majority	 (n=6)	 of	 the	 studies	 were	 conducted	 in	 the	 UK	 (Arthur	 and	
Clifford,	2004,	Hill	et	al.,	1994	and	Hill,	1997,	Hill	et	al.,	2003,	Ndosi	et	al.,	2014,	Ryan	et	al.,	
2006,	Watts	et	al.,	2015),	2	in	France	(Dougados	et	al.,	2015,	Maravic	et	al.,	2000),	and	one	
each	 in	Denmark	 (Primdahl	et	al.,	2014)	and	 in	The	Netherlands	 (Tijhuis	et	al.,	2003).	The	
purpose	of	all	studies	was	to	evaluate	patient	outcome.		
Seven	of	the	prospective	studies	assessed	the	effects	of	nurse-led	care	by	comparing	
patient	 outcomes	 following	 nurse-led	 care	 or	 usual	 (physician-led)	 care	 (Hill	 et	 al.,	 2003,	
Ndosi	et	al.,	2014,	Primdahl	et	al.,	2014,	Ryan	et	al.,	2006,	Watts	et	al.,	2015)	or	team	care	
(Tijhuis	 et	 al.,	 2003).	 The	 other	 two	 studies	 (Dougados	 et	 al.,	 2015,	Maravic	 et	 al.,	 2000)	





efficacy	 of	 nurse-led	 care	 in	 managing	 co-morbidities	 and	 patients’	 self-assessment	 of	
rheumatoid	arthritis	disease	activity.	Maravic	et	al.,	(2000)	was	not	a	comparative	study	but	
the	effects	of	 the	nursing	care	were	assessed	within	 the	context	of	multidisciplinary	care,	
with	 patient	 outcomes	 and	 costs	 followed	 prospectively	 for	 six	 months.	 The	 last	 study	






the	 randomised	 controlled	 trials	 satisfied	 all	 11	 questions	 of	 the	 CASP	 appraisal	 tool	
(Primdahl	et	al.,	2014),	3	satisfied	10	of	the	11	questions	(Dougados	et	al.,	2015,	Ndosi	et	al.,	





From	 the	 study	 summaries	 (Tables	 1-2)	 the	 nursing	 sensitive	 outcomes	 and	
measurements	instruments	were	identified	and	categorised	into	domains	and	mapped	onto	
the	 OMERACT	 Filter	 2.0	 four	 core	 areas	 (Table	 4)	 (Section	 2.7).	 In	 total,	 10	 domains	 for	
health	intervention	were	identified,	these	included:	(i)	disease	status,	(ii)	effectiveness,	(iii)	
safety,	(iv)	function,	(v)	knowledge,	(vi)	satisfaction,	(vii)	psychological	status,	(viii)	quality	of	
life,	 (ix)	 costs	 and	 (x)	 death.	 These	 domains	 were	 derived	 from	 the	 17	 nursing	 sensitive	
outcomes	 	 identified,	 including,	 (1)	 disease	 activity,	 (2)	 clinical	 effects,	 (3)	 pain,	 (4)	 early	
morning	 stiffness	 (EMS)	 duration,	 (5)	 fatigue,	 (6)	 patient	 safety	 issues,	 (7)	 function,	 (8)	
knowledge,	 (9)	 patient	 satisfaction,	 (10)	 confidence	 in	 care	 received,	 (11)	 mental	 health	
status,	(12)	self-efficacy,	(13)	patient	attitude/perception	of	ability	to	control	arthritis,	(14)	
quality	of	 life,	 (15)	health	utility,	 (16)	health	 care	 resources,	and	 (17)	death.	A	 total	of	59	





disease	 status,	 effectiveness	 and	 safety	 (Table	3).	 These	were	 further	 subcategorised	 into	
groups	of	 nursing	 sensitive	outcomes	 as	 considered	 appropriate,	 as	 explained	below.	 The	
domain	of	disease	status	had	only	one	nursing	sensitive	outcome,	namely	disease	activity,	
which	was	 assessed	within	 8	 studies	 through	a	 combination	of	 patient	 reported	outcome	
measures	 and	 biologic	 measures	 and	 reports.	 The	 patient	 reported	 outcome	 measures		
included	 joint	 assessment	 using	 the	 composite	 disease	 activity	 score	 (DAS),	 the	 Richie	
articular	 index	 (RAI),	 and	 the	 rheumatoid	 arthritis	 disease	 activity	 assessment	 (RADAI),	
global	 health	 score	 (GH)	 visual	 analogue	 scale	 (VAS),	 physician	 and	 patient	 global	
assessment-VAS,	 and	 patient	 reported	 disease	 activity.	 Biological	 measures	 and	 reports	








In	 the	 effectiveness	 domain	 four	 nursing	 sensitive	 outcomes	 were	 identified	 in	 7	
studies,	 namely,	 clinical	 effects,	 pain,	 early	morning	 stiffness	 (EMS)	duration,	 and	 fatigue.	
Clinical	 effectiveness	 as	 a	 domain	 was	 also	 assessed	 through	 a	 combination	 of	 patient	
reported	 outcome	 measures	 and	 biological	 measures	 and	 reports.	 Patient	 reported	
outcome	 measures	 included	 Rheumatology	 Attitude	 Index	 (RAI)	 and	 DAS28.	 Biological	
measures	 included	 biochemical	 measures	 of	 CRP,	 ESR,	 plasma	 viscosity,	 and	 urinalysis;	
radiographic	 imaging	of	hands	and	feet;	self-reported	side	effects.	Pain	and	early	morning	
stiffness	 (EMS)	 were	 assessed	 using	 patient	 reported	 outcome	measures	 only,	 namely,	 a	
pain	 5-point	 ordinal	 scale;	 pain-VAS;	 Arthritis	 Impact	 Measurement	 Scale	 (AIMS);	
Rheumatoid	Arthritis	 Impact	of	Disease	(RAID);	EMS	duration	 in	minutes.	Similarly,	 fatigue	
was	assessed	using	a	fatigue-VAS	and	the	RAID	fatigue	scale	(Dougados	et	al.,	2015,	Hill	et	
al.,	 1994,	 Hill	 et	 al.,	 2003,	Maravic	 et	 al.,	 2000,	 Primdahl	 et	 al.,	 2014,	 Ryan	 et	 al.,	 2006,	
Tijhuis	et	al.,	2003).		
The	 patient	 safety	 domain	 had	 only	 patient	 safety	 issue	 as	 a	 nursing	 sensitive	
outcome,	identified	in	two	studies.	These	were	assessed	by	monitoring	and	documentation	
of	 adherence,	 out	 of	 range	 blood	 tests,	 missing	 relevant	 reaction	 on	 out	 of	 range	 tests,	
RADAI	 alerts,	 Health	 assessment	 Questionnaire-(HAQ)-alerts,	 side-effect	 alerts,	 total	





The	 life	 impact	 domain	 related	 to	 function	 was	 identified	 as	 a	 nursing	 sensitive	
outcome	measured	 through	nine	different	 tools	 across	10	 studies	 (Dougados	et	 al.,	 2015,	
Hill,	1997,	Hill	et	al.,	1994,	Hill	et	al.,	2003,	Maravic	et	al.,	2000,	Ndosi	et	al.,	2014,	Primdahl	
et	 al.,	 2014,	 Ryan	 et	 al.,	 2006,	 Tijhuis	 et	 al.,	 2003,	Watts	 et	 al.,	 2015).	 Patient	 reported	
outcome	measures	 	used	to	assess	 function	 included	the	AIMS;	HAQ-Disability	 index	 (-DI);	
modified	 HAQ	 (mHAQ);	 Nottingham	 Health	 Profile	 (NHP);	 McMaster	 Toronto	 Arthritis	
Patient	 Preference	 Disability	 Questionnaire	 (MACTAR);	 Short-form-12	 (SF-12)	 physical	
health	 composite	 score	 (PSC)	 and	 RAID.	 Biological	 measures	 and	 reports	 used	 to	 assess	
function	included	grip	strength	and	documented	aids	and	adaptations.		
The	 patient	 knowledge	 domain	 had	 one	 nursing	 sensitive	 outcome,	 knowledge,	
measured	in	2	studies	(Hill	et	al.,	1994,	Hill	et	al.,	2003).	This	patient	reported	outcome	was	
measured	 using	 the	 Patient	 Knowledge	 Questionnaire	 (PKQ).	 The	 patient	 satisfaction	










The	 psychological	 status	 domain	 had	 three	 nursing	 sensitive	 outcomes,	 namely,	
mental	 health,	 self-efficacy	 and	 patient	 attitude/perception	 of	 ability	 to	 control	 arthritis,	
measured	in	6	studies	(Dougados	et	al.,	2015,	Hill,	1997	and	Hill	et	al.,	1994,	Maravic	et	al.,	
2000,	Ndosi	et	al.,	2014,	Primdahl	et	al.,	2014,	Ryan	et	al.,	2006),	using	the	following	patient	
reported	 outcome	 measures	 :	 AIMS,	 NHP;	 SF-12	 mental	 health	 composite	 score	 (MCS);	
arthritis	self-efficacy	scale	Danish	version	(ASES-DK);	rheumatoid	arthritis	self-efficacy	scale	
(RASE);	 rheumatology	 attitude	 index	 (RAI);	 hospital	 anxiety	 and	 depression	 scale	 (HADS),	
and	RAID.		
Quality	 of	 life	 was	 the	 final	 domain	 in	 this	 area	 and	 the	 only	 nursing	 sensitive	
outcome	measured	 in	5	 studies	 (Dougados	et	al.,	 2015,	Maravic	et	al.,	 2000,	Ndosi	et	al.,	
2014,	Primdahl	et	al.,	2014,	Tijhuis	et	al.,	2003),	all	of	which	used	patient	reported	outcomes		




outcomes,	 namely,	 health	 utility	 and	 health	 care	 resource	 use,	 measured	 in	 5	 studies	
(Dougados	et	al.,	2015,	Ndosi	et	al.,	2014,	Ryan	et	al.,	2006,	Tijhuis	et	al.,	2003,	Watts	et	al.,	
2015).	 The	 patient	 reported	 outcome	 measure	 used	 was	 the	 EuroQoL	 (EQ5D)	 health	
economic	questionnaire,	while	resource	use	was	captured	from	records	of	health	care	data;	
number	 of	 hospitalisations;	 use	 of	 home	 help;	 drug	 use;	 consultation	 with	 other	 health	







patient	 reported	 outcome	 measures.	 Evidence	 of	 instrument	 applicability	 in	 the	 chosen	
scope	 is	a	requirement	of	 the	OMERACT	Filter	2.0	 in	the	process	of	core	set	development	
(Boers	et	al.,	2014).	By	and	large,	the	authors	of	the	included	studies	cited	validation	papers	






arthritis.	All	outcomes	 identified	were	 in	keeping	with	the	broad	conceptual	 framework	of	
OMERACT	 Filter	 2.0	 encompassing	 pathophysiological	manifestation,	 life	 impact,	 resource	
use	and	economic	impact,	and	death	related	to	rheumatoid	arthritis.	Rheumatology	nurses	
are	 an	 integral	 part	 of	 the	 multidisciplinary	 team	 contributing	 to	 the	 coordination	 and	
delivery	of	patient	 care.	Assessing	 the	 value	of	nursing	 contribution	has	been	a	 challenge	








nursing	 sensitive	 outcomes	 will	 help	 demonstrate	 the	 evidence	 of	 rheumatology	 nursing	
effectiveness	so	that	their	contribution	can	be	acknowledged	and	valued.			
Our	 results	 contribute	 to	 advancement	 of	 nursing	 science	 in	 terms	 of	 outcome	
measurement	 in	 rheumatoid	 arthritis	 and	 may	 be	 extended	 to	 other	 inflammatory	
arthritides	(ankylosing	spondylitis	and	psoriatic	arthritis).	 It	 is	 interesting	to	find	that	many	
core	outcomes	measured	in	routine	clinical	care	are	also	sensitive	to	nursing	interventions.	
The	 fact	 that	 nursing	 interventions	 reported	 in	 most	 included	 studies	 involved	 disease	
management	as	part	of	holistic	care	may	account	for	this.	Working	in	extended	role	capacity	
blurs	 the	 professional	 boundaries	 in	 order	 to	 meet	 patients’	 needs;	 therefore	 it	 is	 not	
surprising	 that	 most	 routine	 clinical	 outcomes	 (such	 as	 disease	 activity,	 pain,	 morning	
stiffness	 and	 fatigue)	 were	 also	 nursing	 sensitive	 outcomes.	 It	 is	 worth	 mentioning	 that	
nurses’	 roles	 differ	 across	 countries	 depending	 on	 legal	 frameworks,	 health	 policy	 and	
funding	 for	 health,	 and	 differences	 in	 educational	 systems.	While	 extended	 roles	 are	 not	
practised	 everywhere	 and	 studies	 often	 lack	 an	 extensive	 description	 of	 nurses’	 roles	 and	
responsibilities,	 it	 is	 still	 important	 to	 delineate	 nursing	 sensitive	 outcomes	 as	 these	 may	
contribute	towards	the	development	of	more	detailed	recommendations	for	the	role	of	the	
nurse	in	the	care	of	people	with	rheumatoid	arthritis.	
While	 routine	 clinical	 outcome	 measures	 were	 identified,	 the	 number	 of	 patient	
reported	outcome	measures	was	many	and	varied.	Further	research	is	warranted	to	test	the	
properties	 of	 each	 patient	 reported	 outcome	 measure,	 within	 the	 context	 of	 nursing	
sensitive	 outcomes.	 Then,	 recommendations	 can	 be	 made	 as	 to	 which	 patient	 reported	
outcome	 measures	 should	 be	 used	 to	 best	 assess	 aspects	 of	 care	 when	 evaluating	 the	
impact	of	rheumatology	nursing.	Appropriate	measures	would	include	those	focused	on	the	
ten	nursing	domains	 reported	here	 i.e.	 (i)	 disease	 status,	 (ii)	 effectiveness,	 (iii)	 safety,	 (iv)	
function,	 (v)	 knowledge,	 (vi)	 satisfaction,	 (vii)	 psychological	 status	 (viii)	 quality	 of	 life,	 (ix)	
costs	and	(x)	death.	Although	death	was	reported	in	one	study	(Primdahl	et	al.,	2014),	this	
was	 not	 presented	 as	 an	 outcome	 of	 the	 interventions.	 All	 clinical	 trials	 are	 required	 to	
report	all	serious	events	(including	death)	therefore	making	death	an	implicit	outcome	in	all	
clinical	 studies.	 Our	 results	 provide	 a	 good	 foundation	 upon	 which	 to	 develop	
methodologically	sound	research	designs	to	further	examine	the	multidimensional,	complex	
and	 complementary	 role	 that	 rheumatology	 nursing	 plays	 in	 the	 care	 of	 people	 with	
rheumatoid	arthritis	(Campbell	et	al.,	2000,	Craig	et	al.,	2008).	
The	 importance	 of	 outcome	 research	 and	 the	 challenges	 of	 identifying	 outcomes	
sensitive	to	advanced	nursing	practice	have	been	discussed	(Kleinpell	and	Gawlinski,	2005,	
Resnick,	 2006).	 These	 reports	 reflect	 the	 evolution	 of	 rheumatology	 nursing	 practice	 into	
what	 can	 be	 described	 as	 multilevel	 nursing	 practice	 (Begley	 et	 al.,	 2010).	 With	 this	
evolution	of	nursing	practice	comes	the	seminal	caveat	which	urges	nurses	to	capture	both	
the	art	and	science	of	high	 level	nursing	care	 (Wiedenbach,	1963).	The	question	as	 to	 the	
‘added	 value’	 the	 ‘art	 of	 nursing’	 brings	 to	 bear	 on	 patient	 outcome	 remains	 a	 challenge	







proposed	 approach	 used	 to	 comprehensively	 evaluate	 the	 impact	 of	 advanced	 practice	
nursing	 is	 a	 model	 which	 encompasses	 (i)	 symptomatology,	 (ii)	 quality	 of	 life,	 (iii)	 social	




rheumatology	 nurse	 in	 providing	 added	 value	 to	 the	 care	 of	 patients	 with	 the	 chronic,	




conceptual	 framework	 for	 health.	 This	 framework	 is	 respected	 across	 the	 rheumatology	
communities	where	 it	has	been	 in	use	since	1992.	 It	was	the	framework	of	choice	for	this	
review	so	as	to	maintain	alignment	with	the	wider	rheumatology	community.	Both	another	
strength	 and	 attraction	 is	 the	 involvement	 of	 multinational	 researchers	 and	 active	
involvement	of	patient	partners	 in	the	OMERACT	review	process	 in	keeping	with	what	has	
become	 international	 best	 practice	 (de	Wit	 et	 al.,	 2011,	 Kirwan	 et	 al.,	 2008,	 Speight	 and	
Barendse,	 2010).	 The	 patient	 research	 partners	 participated	 as	 full	 researchers	 in	 the	
discussion	 about	 the	 necessity	 of	 this	 work;	 design	 of	 the	 review;	 study	 selection	 and	 in	









development,	 delivery	 and	 testing	 of	 the	 varied	 interventions.	 Therefore,	 this	 review	 can	
only	confirm	that	nurses	had	a	role	in	the	interventions.	Furthermore,	as	this	review	did	not	
intend	to	delineate	the	role	of	the	members	of	the	multidisciplinary	team,	we	acknowledge	
that	nursing	 sensitive	outcomes	are	not	exclusive	 to	nursing,	 as	 the	 contribution	of	other	
healthcare	professionals	may	also	influence	these	outcomes.				
5. Conclusions	
This	 systematic	 literature	 review	 identified	 the	 extent	 and	 nature	 of	 recognised	
patient	 outcomes	 in	 rheumatoid	 arthritis	 that	 may	 be	 affected	 by	 rheumatology	 nursing	
interventions.	 Furthermore,	 the	 review	 provides	 robust	 evidence	 that	 the	 delineated	
validated	 instruments,	 used	 in	 RCTs	 and	 increasingly	 in	 routine	 clinical	 practice,	 are	
appropriate	for	use	in	all	studies	which	aim	to	evaluate	the	impact	of	nursing	interventions	
on	 patient	 outcome	 in	 rheumatoid	 arthritis.	 The	 alignment	 of	 these	 nursing	 sensitive	







set	of	outcomes	to	be	measured	 in	all	nursing	 intervention	studies	 involving	patients	with	
rheumatoid	 arthritis.	 Further	 research	 is	 needed	 to	 strengthen	 our	 knowledge	 about	 the	
contributions	of	nursing	sensitive	outcomes	to	the	OMERACT	Filter	2.0.	Moreover,	 further	
exploratory	study	is	required	to	more	comprehensively	examine	aspects	of	patient-centered	
care	 unique	 to	 rheumatology	 nursing	 in	 order	 to	 optimise	 the	 impact	 of	 nursing	 both	 in	

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1	 1	 1	 1	 1	 1	 1	 9	 Do	you	believe	
the	results?		
1	 1	 1	




	 	 	 	 	 	 	 	 	 11		 Do the results of 






10	 7	 9	 10	 11	 10	 9	 	 Total			 8	 9	 11	








































































		 	 Stiffness	 EMS	duration	in	minutes	(Hill	et	al.,	1994,	Hill	et	al.,	
2003,	Ndosi	et	al.,	2014)	
		
















































































































		 	 	 Use	of	home	help	
(Tijhuis	et	al.,	2003)Drug	
use	(Tijhuis	et	al.,	2003)	





		 	 	 Changes	in	RA	DMARD	
therapy	(Dougados	et	
al.,	2015)	
		 		 		 Measures	taken	against	
comorbidities	
(Dougados	et	al.,	2015)	
Death	 Death	 Death**	 		 Death	(Primdahl	et	al.,	
2014)	
**	Reporting	mortality	is	a	regulatory	requirement	for	all	clinical	studies.	
Table	4	legend	
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*Index	paper	reference	provided	by	author	
Abbreviations	in	alphabetical	order	:	AIMS:	Arthritis	Impact	Measurement	Scale,	ASES,	Arthritis	Self-Efficacy	Scale,	CNS:	clinical	nurse	specialist	
CRP:	C-reactive	protein,DAS28:	Disease	Activity	Score	28	joints,	EMS:	early	morning	stiffness	duration,	EQ5D:	EuroQoL,	ESR:	erythrocyte	
sedimentation	rate,		HADs:	Hospital	anxiety	and	depression	scale,	HAQ-DI:	health	assessment	questionnaire	disability	index,	LSQ,	Leeds	
Satisfaction	Questionnaire,	MACTAR:	McMaster	Toronto	Arthritis	Patient	Preference	Disability	Questionnaire,	MCS:	Mental	health	composite	
score,	MHAQ	Modified	Health	Assessment	Questionnaire,	NHP:	Nottingham	Health	Profile,	PCS:	Physical	health	composite	score,	PKQ:	Patient	
Knowledge	Questionnaire,	RADAI	:Rheumatoid	arthritis	disease	activity	index,	RAI:	Rheumatology	Attitude	Index,	RAID	Rheumatoid	Arthritis	
Impact	of	Disease	RAND:	RAND	36-item	Health	Survey,	RAQoL:	Rheumatoid	Arthritis	Quality	of	Life	Scale,	RASEQ:	Rheumatoid	arthritis	self-
efficacy	questionnaire,	SF-12;	short-form	12;	SJW:	swollen	joint	count,	TJC:	Tender	joint	count,	VAS:	visual	analogue	scale.		
	
	
